Torrent Pharma Share Price Rises 3.02%; Reports 15% PAT Growth in FY25 Results & Declares ₹6 Final Dividend

Torrent Pharmaceuticals Limited reported a consolidated revenue of ₹11,516 crore for the financial year ended March 31, 2025, marking a 7% year-on-year (YoY) growth compared to ₹10,728 crore in FY24. For the fourth quarter (Q4 FY25), revenue stood at ₹2,959 crore, up 8% YoY from ₹2,745 crore.

Operational Performance

The company maintained healthy operational efficiency with a gross margin of 75.3% in Q4 FY25, consistent with the same period last year. Operating EBITDA grew by 9% YoY in the quarter, reaching ₹964 crore, and the margin improved slightly to 32.6% versus 32.2% in Q4 FY24. On a full-year basis, operating EBITDA came in at ₹3,721 crore, reflecting a 10% increase from FY24.

Profitability Boosted Despite Exceptional Items

Torrent Pharma’s net profit after tax (PAT) for Q4 FY25 was ₹498 crore, registering an 11% YoY rise. When adjusted for exceptional items related to the closure of DPCO litigation, PAT growth for the quarter stood at a higher 15%. For the full year, PAT reached ₹1,911 crore, up 15% YoY from ₹1,656 crore in FY24.

R&D Investments Remain Strong

The company continued to invest in future growth through research and development (R&D), spending ₹581 crore in FY25, which was 5% of total revenue. This represents a 10% increase over the previous year’s R&D expenditure.

Leadership Update: Aman Mehta Appointed MD

As part of its long-term strategic vision and succession planning, the Board has approved the appointment of Aman Mehta as Managing Director, effective August 1, 2025. The company stated that this move reinforces Torrent’s focus on building a future-ready leadership team to drive sustainable stakeholder value.

Dividend Declaration

Torrent Pharma distributed an interim dividend of ₹26 per share during the year. The Board has also recommended a final dividend of ₹6 per share (face value ₹5), subject to shareholder approval.

Torrent Pharmaceuticals Share Price Performance

On May 21, 2025, Torrent Pharmaceuticals share price (NSE: TORNTPHARM) opened at ₹3,245.00, up from its previous close of ₹3,241.50. At 9:40 AM, the share price of Torrent Pharmaceuticals was trading at ₹3,339.50, up by 3.02% on the NSE.

Also Read: Torrent Pharmaceuticals Issues ₹300 Crore Commercial Papers!

Conclusion

Torrent Pharmaceuticals delivered its performance in FY25, with consistent revenue growth, profitability, and continued investment in innovation.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.